{"altmetric_id":21707075,"counts":{"readers":{"mendeley":1,"citeulike":0,"connotea":0},"total":{"posts_count":5},"twitter":{"unique_users_count":4,"unique_users":["fsgfso","fsgfon","OncologyCentral","CancerWallonia"],"posts_count":5}},"selected_quotes":["FREE from used as treatment for postmenopausal women with breast cancer?"],"citation":{"altmetric_jid":"4f6fa63b3cf058f610008df2","authors":["Laura Orlando","Saverio Cinieri"],"doi":"10.2217\/fon-2017-0101","first_seen_on":"2017-07-10T08:29:47+00:00","funders":["niehs"],"issns":["1479-6694","1744-8301"],"journal":"Future Oncology","last_mentioned_on":1500916391,"links":["https:\/\/www.futuremedicine.com\/doi\/full\/10.2217\/fon-2017-0101","https:\/\/www.futuremedicine.com\/doi\/pdf\/10.2217\/fon-2017-0101"],"pmid":"28685586","publisher":" Future Medicine Ltd London, UK ","publisher_subjects":[{"name":"Oncology And Carcinogenesis","scheme":"era"}],"scopus_subjects":["Health Sciences","Medicine","Life Sciences","Biochemistry, Genetics and Molecular Biology"],"subjects":["neoplasms"],"title":"Should endocrine therapy still be used as an initial treatment for postmenopausal women with metastatic breast cancer?","type":"article","mendeley_url":"http:\/\/www.mendeley.com\/research\/endocrine-therapy-still-used-initial-treatment-postmenopausal-women-metastatic-breast-cancer-1"},"altmetric_score":{"score":1.5,"score_history":{"1y":1.5,"6m":1.5,"3m":1.5,"1m":0,"1w":0,"6d":0,"5d":0,"4d":0,"3d":0,"2d":0,"1d":0,"at":1.5},"context_for_score":{"all":{"total_number_of_other_articles":8266541,"mean":6.9778542507441,"rank":3908368,"this_scored_higher_than_pct":50,"this_scored_higher_than":4174372,"rank_type":"exact","sample_size":8266541,"percentile":50},"similar_age_3m":{"total_number_of_other_articles":211599,"mean":11.56557262356,"rank":96236,"this_scored_higher_than_pct":51,"this_scored_higher_than":108872,"rank_type":"exact","sample_size":211599,"percentile":51},"this_journal":{"total_number_of_other_articles":730,"mean":4.161670781893,"rank":258,"this_scored_higher_than_pct":60,"this_scored_higher_than":443,"rank_type":"exact","sample_size":730,"percentile":60},"similar_age_this_journal_3m":{"total_number_of_other_articles":23,"mean":9.5431818181818,"rank":13,"this_scored_higher_than_pct":43,"this_scored_higher_than":10,"rank_type":"exact","sample_size":23,"percentile":43}}},"demographics":{"poster_types":{"member_of_the_public":2,"science_communicator":2},"users":{"twitter":{"cohorts":{"Science communicators (journalists, bloggers, editors)":2,"Members of the public":2}},"mendeley":{"by_status":{"Student  > Postgraduate":1},"by_discipline":{"Medicine and Dentistry":1}}}},"posts":{"twitter":[{"url":"http:\/\/twitter.com\/fsgfso\/statuses\/884328713894146048","license":"gnip","citation_ids":[21707075],"posted_on":"2017-07-10T08:29:30+00:00","author":{"name":"Future Science OA","url":"http:\/\/t.co\/q4tiPlRblq","image":"http:\/\/pbs.twimg.com\/profile_images\/534307524007034880\/rNTC4DiG_normal.jpeg","description":"Advances in basic, translational and clinical research for improving human health | #OpenAccess journal published by Future Science Group. On the #DOAJ","id_on_source":"fsgfso","tweeter_id":"2880872098","followers":1006},"tweet_id":"884328713894146048"},{"url":"http:\/\/twitter.com\/fsgfon\/statuses\/884407832459722753","license":"gnip","rt":["fsgfso"],"citation_ids":[21707075],"posted_on":"2017-07-10T13:43:53+00:00","author":{"name":"Future Oncology Jnl","url":"http:\/\/www.futuremedicine.com\/loi\/fon","image":"https:\/\/pbs.twimg.com\/profile_images\/489034431470911488\/VL6M5Pdz_normal.jpeg","description":"Future Oncology | MEDLINE-indexed journal on advances in basic, translational and clinical oncology research | IF 2.131 | Published by Future Science Group","id_on_source":"fsgfon","tweeter_id":"2647607972","geo":{"lt":null,"ln":null},"followers":1493},"tweet_id":"884407832459722753"},{"url":"http:\/\/twitter.com\/fsgfon\/statuses\/889472846094905345","license":"gnip","citation_ids":[21707075],"posted_on":"2017-07-24T13:10:26+00:00","author":{"name":"Future Oncology Jnl","url":"http:\/\/www.futuremedicine.com\/loi\/fon","image":"https:\/\/pbs.twimg.com\/profile_images\/489034431470911488\/VL6M5Pdz_normal.jpeg","description":"Future Oncology | MEDLINE-indexed journal on advances in basic, translational and clinical oncology research | IF 2.131 | Published by Future Science Group","id_on_source":"fsgfon","tweeter_id":"2647607972","geo":{"lt":null,"ln":null},"followers":1493},"tweet_id":"889472846094905345"},{"url":"http:\/\/twitter.com\/OncologyCentral\/statuses\/889497793374683140","license":"gnip","rt":["fsgfon"],"citation_ids":[21707075],"posted_on":"2017-07-24T14:49:34+00:00","author":{"name":"Oncology Central","url":"http:\/\/t.co\/ypoegiSLi6","image":"http:\/\/pbs.twimg.com\/profile_images\/598508934568288256\/SHAXlRkl_normal.jpg","description":"Oncology Central is the free-of-charge service from Future Science Group offering easy access to breaking news, downloadable images and peer-reviewed articles.","id_on_source":"OncologyCentral","tweeter_id":"1098710533","followers":870},"tweet_id":"889497793374683140"},{"url":"http:\/\/twitter.com\/CancerWallonia\/statuses\/889533933989376001","license":"gnip","rt":["fsgfon"],"citation_ids":[21707075],"posted_on":"2017-07-24T17:13:11+00:00","author":{"name":"CancerWallonia","image":"https:\/\/pbs.twimg.com\/profile_images\/623178120615604224\/unGEOij0_normal.jpg","description":"Cancer: from Wallonia to the World, from the World to Wallonia -  Cancer: la Wallonie parle au Monde, le Monde parle \u00e0 la Wallonie","id_on_source":"CancerWallonia","tweeter_id":"2848852120","geo":{"lt":null,"ln":null},"followers":603},"tweet_id":"889533933989376001"}]}}